Skip to content

Impact of Virtual Reality on Anxiety and Pain During Implantation of Cardiac Implantable Electronic Devices (CIED)

Impact of Virtual Reality on Patients' Anxiety and Pain During Implantation of Cardiac Pacemakers, Implantable Cardioverter-defibrillators, or Cardiac Resynchronization Therapy: a Randomized Controlled Study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07250282
Acronym
CIED
Enrollment
111
Registered
2025-11-26
Start date
2024-01-01
Completion date
2025-11-01
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain

Keywords

CIED, Pacemaker, Virtual reality, ICD, CRT

Brief summary

Purpose: This study aimed to evaluate whether virtual reality technology positively affects patients' pain and anxiety throughout the entire procedure of implantation of cardiac pacemakers, defibrillators, or cardiac resynchronisation therapy.

Detailed description

Methods: From January 2024 to Mai 2025, 111 Patients undergoing implantation of cardiac single-chamber or dual-chamber pacemakers or defibrillators and cardiac resynchronisation therapy were randomized to either a control group (n=55) or an intervention group (n=56). The control group received standard preoperative care using local anaesthesia and on-demand conscious sedation. A virtual reality headset was used in the intervention group in addition to the standard care intraoperatively. The State-Trait Anxiety Inventory-State (STAI-S) questionnaire was filled out by patients preoperative and immediate postoperative to best determine their perioperative state anxiety.

Interventions

OTHERVirtual reality headset

A virtual reality headset was used during the study with the purpose of distracting the patients from painful and stressful stimuli in the operation room to decrease their anxiety and pain perception

Sponsors

Muhammed Kurt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Indication for implantation of a cardiac pacemaker, ICD, or CRT device due to one of the following: * Complete heart block (AV block III°) * Symptomatic bradycardia due to sinus node dysfunction * Tachy-brady syndrome * Atrial fibrillation with slow ventricular rate * Symptomatic bradycardia due to AV block II° type Mobitz * Secondary prevention of sudden cardiac death due to ventricular tachycardia * Primary prevention in patients with heart failure with reduced ejection fraction * Primary prevention in patients with heart failure with reduced ejection fraction and complete left bundle branch block * "Pace and ablate" strategy for therapy-resistant persistent atrial fibrillation * Need to Upgrade to CRT-P due to a high percentage of right ventricular pacing

Exclusion criteria

* Significant language barrier preventing consent or cooperation * severe panic disorder or claustrophobia

Design outcomes

Primary

MeasureTime frameDescription
Preoperative baseline to immediate postoperative anxiety change using State-Trait Anxiety Inventory-State (STAI-S) questionnaire score (Score range between 20 - 80, higher score means greater state anxiety)From enrolment to immediate postoperativeThe perioperative anxiety change of patients defined as reduction in STAI-S anxiety scores from preoperative to immediate postoperative was compared between the groups as the primary endpoint of the study

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026